119 related articles for article (PubMed ID: 7504533)
1. Enzymatic and immunohistochemical evaluation of tyrosine phosphorylation in breast cancer specimens.
Lower EE; Franco RS; Miller MA; Martelo OJ
Breast Cancer Res Treat; 1993; 26(3):217-24. PubMed ID: 7504533
[TBL] [Abstract][Full Text] [Related]
2. Prognostic value of cytosolic tyrosine kinase activity in 249 node-positive breast cancer patients.
Romain S; Chinot O; Klijn JG; van Putten WL; Guirou O; Look M; Martin PM; Foekens JA
Br J Cancer; 1994 Aug; 70(2):304-8. PubMed ID: 8054279
[TBL] [Abstract][Full Text] [Related]
3. [Tyrosine-protein kinase activity in breast neoplasm. Comparison with activity obtained in benign diseases and in normal tissues].
Pierart J; Oñate E; Klaassen R; Cid L; Gutierrez S; Talbot E; Ross E; Zambrano C; Burmeister R; Puchi M
Rev Med Chil; 1995 Feb; 123(2):165-75. PubMed ID: 7569456
[TBL] [Abstract][Full Text] [Related]
4. Tyrosine kinase activity in breast cancer, benign breast disease, and normal breast tissue.
Hennipman A; van Oirschot BA; Smits J; Rijksen G; Staal GE
Cancer Res; 1989 Feb; 49(3):516-21. PubMed ID: 2910471
[TBL] [Abstract][Full Text] [Related]
5. Induction of the differentiated phenotype in human colon cancer cell is associated with the attenuation of subcellular tyrosine phosphorylation.
Schwartz B; Lamprecht SA; Polak-Charcon S; Niv Y; Kim YS
Oncol Res; 1995; 7(6):277-87. PubMed ID: 8527862
[TBL] [Abstract][Full Text] [Related]
6. Protein tyrosine kinase activity in breast cancer and its relation to prognostic indicators.
Kopreski MS; Witters L; Brennan WA; Buckwalter EA; Chinchilli VM; Demers LM; Lipton A
Anticancer Res; 1996; 16(5B):3037-41. PubMed ID: 8920763
[TBL] [Abstract][Full Text] [Related]
7. Increased tyrosine protein kinase activity in hairy cell and monocytic leukemias.
Lower EE; Franco RS; Martelo OJ
Am J Med Sci; 1992 Jun; 303(6):387-91. PubMed ID: 1605167
[TBL] [Abstract][Full Text] [Related]
8. Net increase of platelet membrane tyrosine specific-protein kinase activity by phorbol myristate acetate.
Ishihara N; Sakamoto H; Iwama M; Kobayashi B
Life Sci; 1990; 46(1):29-36. PubMed ID: 2299969
[TBL] [Abstract][Full Text] [Related]
9. Type 1 protein tyrosine kinases in benign and malignant breast lesions.
Suo Z; Emilsen E; Tveit KM; Nesland JM
Histopathology; 1998 Dec; 33(6):514-21. PubMed ID: 9870145
[TBL] [Abstract][Full Text] [Related]
10. Different specificities of spleen tyrosine protein kinases for synthetic peptide substrates.
Donella-Deana A; Brunati AM; Marchiori F; Borin G; Marin O; Pinna LA
Eur J Biochem; 1990 Dec; 194(3):773-7. PubMed ID: 2269299
[TBL] [Abstract][Full Text] [Related]
11. Phosphotyrosyl-proteins in human breast cancer.
Partanen S
Anticancer Res; 1993; 13(5C):1777-80. PubMed ID: 7505541
[TBL] [Abstract][Full Text] [Related]
12. Tissue microarray analysis of signal transducers and activators of transcription 3 (Stat3) and phospho-Stat3 (Tyr705) in node-negative breast cancer shows nuclear localization is associated with a better prognosis.
Dolled-Filhart M; Camp RL; Kowalski DP; Smith BL; Rimm DL
Clin Cancer Res; 2003 Feb; 9(2):594-600. PubMed ID: 12576423
[TBL] [Abstract][Full Text] [Related]
13. DNA-synthesis enzyme activity: a biological tool useful for predicting anti-metabolic drug sensitivity in breast cancer?
Romain S; Martin PM; Klijn JG; van Putten WL; Look MP; Guirou O; Foekens JA
Int J Cancer; 1997 Apr; 74(2):156-61. PubMed ID: 9133448
[TBL] [Abstract][Full Text] [Related]
14. Synthetic peptides reproducing the EGF-receptor segment homologous to the pp60v-src phosphoacceptor site. Phosphorylation by tyrosine protein kinases.
Cola C; Brunati AM; Borin G; Ruzza P; Calderan A; De Castiglione R; Pinna LA
Biochim Biophys Acta; 1989 Jul; 1012(2):191-5. PubMed ID: 2500978
[TBL] [Abstract][Full Text] [Related]
15. Tyrosine protein kinase activity in renal brush-border membranes.
Tremblay L; Gingras D; Boivin D; Béliveau R
Biochim Biophys Acta; 1992 Jul; 1108(2):183-9. PubMed ID: 1637843
[TBL] [Abstract][Full Text] [Related]
16. Increased expression of membrane-associated phospholipase A2 shows malignant potential of human breast cancer cells.
Yamashita S; Yamashita J; Sakamoto K; Inada K; Nakashima Y; Murata K; Saishoji T; Nomura K; Ogawa M
Cancer; 1993 May; 71(10):3058-64. PubMed ID: 8490834
[TBL] [Abstract][Full Text] [Related]
17. Effect of quercetin on activities of protein kinase C and tyrosine protein kinase from HL-60 cells.
Kang TB; Liang NC
Zhongguo Yao Li Xue Bao; 1997 Jul; 18(4):374-6. PubMed ID: 10072927
[TBL] [Abstract][Full Text] [Related]
18. Association of protein tyrosine phosphorylation with B cell differentiation induced by 12-O-tetradecanoylphorbol-13-acetate (TPA).
Kuratsune H; Owada MK; Tokumine Y; Tagawa S; Nojima J; Shibano M; Nishimori Y; Morita T; Machii T; Kitani T
Leukemia; 1990 Oct; 4(10):700-3. PubMed ID: 2214873
[TBL] [Abstract][Full Text] [Related]
19. Elevated content of the tyrosine kinase substrate phospholipase C-gamma 1 in primary human breast carcinomas.
Arteaga CL; Johnson MD; Todderud G; Coffey RJ; Carpenter G; Page DL
Proc Natl Acad Sci U S A; 1991 Dec; 88(23):10435-9. PubMed ID: 1683701
[TBL] [Abstract][Full Text] [Related]
20. Tyrosine kinase activation in breast carcinoma with correlation to HER-2/neu gene amplification and receptor overexpression.
Bhargava R; Naeem R; Marconi S; Luszcz J; Garb J; Gasparini R; Otis CN
Hum Pathol; 2001 Dec; 32(12):1344-50. PubMed ID: 11774167
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
